Align Technology (ALGN) is a health care supplies company in the Health Care sector. Listed on the NASDAQ, Align Technology is a component of the S&P 500 index. As of 2026-06-10, the stock is trading at $170.50.
Key Metrics & Risk
Based on 5-year historical data from Yahoo Finance (daily returns, annualized using 252 trading days).
| Metric | Value |
|---|---|
| Latest Price | $170.50 |
| Latest Date | 2026-06-10 |
| Expected Return (Annualized) | -12.87% |
| Risk / Std Dev (Annualized) | 49.60% |
| Sharpe Ratio (rf=4.5%) | -0.35 |
S&P 500 Context
- Sector: Health Care
- Sub-Industry: Health Care Supplies
- Exchange: NASDAQ
- Index: S&P 500 Component
Risk/Return Profile
The stock shows an annualized expected return of -12.87% with an annualized volatility of 49.60%. The Sharpe ratio of -0.35 (assuming 4.5% risk-free rate) indicates negative risk-adjusted returns relative to the risk-free rate.
Modern Portfolio Theory Positioning
This stock is plotted on the S&P 500 Modern Portfolio Theory chart which visualizes the risk/return trade-off across all S&P 500 components. The chart uses Sharpe ratio as the color dimension, allowing quick identification of stocks with superior risk-adjusted performance.
Fundamentals
| Metric | Value |
|---|---|
| Market Cap | 12.21B |
| Enterprise Value | 11.27B |
| Trailing P/E | 28.66 |
| Forward P/E | 13.78 |
| Price to Book | 2.94 |
| Price to Sales | 2.98 |
| EV/Revenue | 2.75 |
| EV/EBITDA | 12.65 |
| Profitability | | | Profit Margin | 10.5% | | Operating Margin | 16.59% | | ROE | 10.82% | | ROA | 7.33% |
| Growth | | | Revenue Growth | 6.2% | | Earnings Growth | 23.9% |
| Financial Health | | | Total Revenue | 4.1B | | Total Debt | 0.12B | | Total Cash | 1.06B | | Free Cash Flow | 0.54B | | Operating Cash Flow | 0.69B |
| Price & Technical | | | 52W High | $208.31$ | | 52W Low | $122.0$ | | 50-Day Avg | $173.09$ | | 200-Day Avg | $158.99$ | | Beta | 1.67 | | Shares Outstanding | 0.07B | | Float Shares | 0.07B | | Insider Holdings | 6.82% | | Institutional Holdings | 101.71% | | Short Ratio | 4.43 | | Short % of Float | 7.38% |
| Analyst Targets | | | Target High | $240.0$ | | Target Low | $175.0$ | | Target Mean | $209.07$ | | Target Median | $214.0$ | | # of Analysts | 14 | | Recommendation | buy |
Disclaimer
This analysis is for educational purposes only and does not constitute financial advice. Past performance is not indicative of future results. Always conduct your own research or consult a qualified financial advisor before making investment decisions.